search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
MALE GROOMING


Finally, recent immunohistochemistry studies suggest that sweat glands produce and excrete antimicrobial peptides such as dermcidin, cathelicidin, and lactoferrin pointing to a potential role of sweating in host defense against skin infection.9,10,11,12


Malodour formation on human axillary The moist environment of the human axilla is characterized by the presence of oily and odourless fluids containing proteins, cholesterol, steroid derivatives, squalene and a wide range of lipids.13


These substances are


secreted by eccrine, sebaceous and apocrine glands specifically located in the underarm region of the human body and some of which are stimulated by emotional stress.14,15 Emotional sweating does not occur


until puberty and is often associated with development of strong body odour.2


In the


past few decades, several studies have focused on the relationship between these odourless sweat secretions and the formation of a strong body odour. It has been known since the 1950s that the metabolic activity of microorganisms that inhabit the skin surface is essential for the development of body odour.2 Nevertheless, closer investigation of the


bacterial community structure in the axillary microenvironment showed that it is usually colonized by four major groups of bacteria, namely staphylococci, aerobic coryneforms, propionibacteria and micrococci.16


High


levels of strong body odour were observed in individuals with a microflora dominated by aerobic coryneforms, whereas staphylococci- dominated axillae only revealed low levels of odour.17 Until now, several routes of odour


formation have been detected including the transformation of glycerol and lactic acid, and the conversion of aliphatic amino acids into volatile fatty acids.18 Of all, the four routes most extensively studied and the generally accepted mechanisms are as follows: (i) the biotransformation of steroids, (ii) the release of short branched-chain fatty acids from glutamine-conjugates, (iii) the release of short sulfanylalkanols from glycine- cysteine- or cysteine-(S)-conjugates and (iv) the biotransformation of long-chain fatty acids into volatile short branched-chain fatty acids.1 It is now generally accepted that


Figure 3: Biotransformation of sweat and sebum O OH Figure 4: Structure of Caprylyl Glyceryl Ether


skin bacteria cause body odour by biotransformation of sweat and components secreted in the human axillae, especially aerobic corynebacteria have been shown to contribute strongly to axillary malodor. Analysis of odouriferous sweat components has shown that the major odour-causing substances in human sweat include steroid derivatives, short volatile branched-chain fatty acids, sulphanylalkanols and Diacetyl (2,3-butanedione)(Figure 2 & 3).1,19


Approaches to body odour control There are at least four formulation approaches


TABLE 1: MIC VALUES OF CAPRYLYL GLYCERYL ETHER AND ETHYLHEXYLGLYCERIN ON BACTERIA, INCLUDING BODY ODOUR RELATED BACTERIA STRAIN


MIC in ppm pH 7.0


Staphylococcus aureus (G+) Corynebacterium jeikeium (G+) Brevibacterium linens (G+) Corynebacterium xerosis (G+) Pseudomonas aeruginosa (G-) Escherichia coli (G-)


Enterobacter aerogenes (G-) Klebsiella pneumoniae (G-) Burkholderia cepacia (G-) Enterobacter gergoviae (G-) Citrobacter freundii (G-)


www.personalcaremagazine.com


Ethyhexylglycerin 1000 1000 1500 1000 >1000 7500


10000 500


3000


>10000 10000


Caprylyl Glyceryl Ether 500


1000 1500 1500


>10000 7500 3000 <250 750


>10000 5000


in creating cosmetic products targeting the body odour control. ■ Antiperspirants. This approach consists in formation of temporary plugs in the upper parts of the sweat pores by very acidic aluminum complexes. These antiperspirant substances also inhibit bacterial growth since they create acidic environment and reduce moisture in the axilla. ■ Antimicrobial deodorant agents. Second approach is to use molecules with antimicrobial activity and specific enzyme inhibition activity that specifically targets skin bacteria mainly Corynebacterium species involved in biotransformation of sweat, lipids and proteins into odourous substances, by reducing microbial count and their activity and metabolism. ■ Odour masking ingredients. The third strategy is odour-masking with efficient tailor- made fragrance compositions, incapsulated fragrances, essential oils and by using substances like clays, minerals and starches that could absorb moisture, sweat, sebum and odourous substances. ■ Fatty acids neutralizers. The fourth approach can involve efficient neutralization of short volatile fatty acids with alkaline ingredients like sodium bicarbonate and Magnesium minerals The optimal solution is based on the synergy of different molecules with multiple functions to


September 2022 PERSONAL CARE OH


BODY ODOUR


51


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104